BOT 5.26% 36.0¢ botanix pharmaceuticals ltd

Ann: Dermatology Asset Acquired to Accelerate Path to Revenue, page-16

  1. 514 Posts.
    lightbulb Created with Sketch. 319
    this should derisk the company and we will hopefully see funds start buying in.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.